10.1016/j.jaut.2020.102433
2020.03.03.972133v1
10.1101/2020.04.13.039917
10.1007+s10156-003-0296-9
10.1016/j.apsb.2020.02.008
10.1101/2020.03.21.20040691
nrd.2015.37
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032715
10.1101/2020.03.19.997890
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032720
10.1128/JVI.78.20.11334–11339.2004
s41586-020-2223-y
10.1101/2020.01.28.922922
COVID-19_paper-final_01-03-20_CHA
10.1016/j.jcv.2004.03.003
10.1038/nrd.2015.37
10.1101/2020.04.05.20054254
Kaggle
10.1101/2020.04.05.026187
10.5582/bst.2020.01020
10.1101/2020.03.20.999730
10.1101/2020.04.07.028589
10.1021/jm0493008
10.1101/2020.04.06.026476
preprints202003.0024.v1
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032718
preprints202002.0418.v2
preprints202003.0239.v1
10.1101/2020.04.04.020925
10.1101/2020.03.09.20033068v2
10.1038/s41422-020-0282-0
1-s2.0-S0166354213003355
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032716
https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032717
1-s2.0-S0166354213002234
10.1016/j.ijantimicag.2018.05.003
10.1371/journal.pmed.0030343
10.1101/2020.03.18.20038190v2
10.1093+infdis+jiv392
1-s2.0-S235277141630074X
10.1101/2020.03.03.972133
10.1101/2020.03.22.002386v1
10.1016+j.jfma.2013.11.006
10.2174/1871528114666151022150122
10.1177/095632020501600205
ddr.21656
10.7150/ijbs.45538
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032719
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032713
10.1016/j.antiviral.2020.104787
10.3201/eid1004.030458
10.1101/2020.03.25.008482v1
10.1101/2020.03.22.20034041
10.1128/AAC.03036-14
10.1101/2020.04.15.997254
10.3390/v10120721
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032712
10.1101/2020.04.03.023846
10.2147/IJN.S31379
https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032714